R&D + Strategic Partnering For The
Global Vaccine Industry

Dr. Kate O’Brien is the Director of the Immunization, Vaccines and Biologicals (IVB) Department at the World Health Organization (WHO). In this role she is responsible for leading WHO’s vaccine and immunization strategy and implementation to advance the vision of a world where...

Dr. Florika Fink-Hooijer DIRECTOR-GENERAL, HEALTH EMERGENCY, PREPAREDNESS & RESPONSE AUTHORITY (DG HERA) Dr. Florika Fink-Hooijer leads the DG HERA in the European Commission. DG HERA’s primary mission is to counter vulnerabilities and strategic dependencies within the EU in relation to...

Dr. Veterinary Medicine, virologist, active in global networking in human and animal health, vaccines and diagnostics, global disease control, one health, public affairs with EU, WHO, Asian and African authorities and experienced in vaccine translational development. CV in brief: Research...

Michael C Caldwell MD MPH | Assoc VP Vaccine ResearchMeharry Medical College Michael C Caldwell, Assoc VP Vaccine Research, Meharry Medical CollegeDr. Caldwell is the Associate Vice President, Vaccine Research & Education at Meharry Medical College in Nashville TN.  He is Professor of Global...

Richard White is a Prof in Infectious Disease Epidemiology in the TB Modelling Group, TB Centre, Vaccine Center and Math Modelling Centre at the London School of Hygiene and Tropical Medicine. He was awarded a PhD in infectious disease modelling in 2006, led the establishment of the LSHTM’s Centre...

Dr. Luigi Buonaguro is the Director of the Innovative Immunological Models at the National Cancer Institute - IRCCS “Pascale ”, Naples – Italy. He is an expert in identification and characterization of tumor antigens for preventive/therapeutic cancer vaccine development. His focus is mostly on...

Dr Bassam Hallis OBE is the Deputy Director and the lead for the Vaccine Development and Evaluation Centre. Bassam has over 35 years’ experience working with public sector, industry and academia in the development and evaluation of vaccines and therapeutics. He provides scientific and operational...

Stephen Lockhart DM, FFPM, FMedSci. I qualified in Medicine from the University of Oxford in 1980.  After working around the UK in hospital medicine and research, I joined the pharmaceutical industry in 1986.  For over 30 years I have been engaged in global vaccine clinical R&D in...

Hanneke Schuitemaker, Ph.D., is the Chief Scientific Officer at Valneva, Austria, with responsibility for pre-clinical and translational R&D for prophylactic vaccines against infectious diseases. Before joining Valneva, she served for almost 14 years as the Head of Viral Vaccine Discovery and...

Nico Vandaele obtained a PhD in Business Engineering, Operations Management and Operations Research in 1996. Being a professor at KU Leuven since then, his research focus was on (bio-pharma) supply chains. In the last decade, the focus was on embedding the supply chain in broader health...

Pete joined LifeArc from Wellcome in Sep 2024 as Scientific Director in the Global Health team.  He's an Immunologist with >20 years in the life sciences, >12 years bridging R&D across academia and Industry and 8 years strategy, public/private partnerships and portfolio investment in...

Anja Schreijer is a medical specialist in infectious disease control who has worked for various national and international governments, WHO and ECDC. During the Covid-19 pandemic, she chaired the National Consultation on Infectious Disease Control, which was responsible for making scientifically...

As Professor in molecular virology my R&D focus is on the design, development and deployment of viral pseudotype based neutralisation assays for influenza, coronavirus and other emerging viruses, and I have received funding from the MRC, the Bill & Melinda Gates Foundation, Innovate UK, the ...

Dr. Alessandro Manenti graduated in Biology obtaining his Bachelor’s Degree in 2009 and a Master’s Degree in Molecular Evolution in 2013 at the University of Siena. He worked for six months in a big company in the field of Life Sciences (Novartis). In November 2013, he won a competition for PhD...

Miguel Prudêncio completed his PhD by the University of East Anglia (UK) in 2000, followed by a post-doctoral period at the University of Leiden (NL). In 2004, he initiated his research careeer in the field of malaria, at Instituto de Medicina Molecular (iMM, PT), now the Gulbenkian Institute for...